Sun Yangbai, Cai Jiangyu, Yu Shiyang, Chen Shuai, Li Fengfeng, Fan Cunyi
Department of Orthopaedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China.
Sci Rep. 2016 Mar 4;6:22729. doi: 10.1038/srep22729.
Heterotopic ossification (HO) is the abnormal formation of mature bone in extraskeletal soft tissues that occurs as a result of inflammation caused by traumatic injury or associated with genetic mutation. Despite extensive research to identify the source of osteogenic progenitors, the cellular origins of HO are controversial and the underlying mechanisms, which are important for the early detection of HO, remain unclear. Here, we used in vitro and in vivo models of BMP4 and TGF-β2-induced HO to identify the cellular origin and the mechanisms mediating the formation of ectopic bone in traumatic HO. Our results suggest an endothelial origin of ectopic bone in early phase of traumatic HO and indicate that the inhibition of endothelial-mesenchymal transition by miR-630 targeting Slug plays a role in the formation of ectopic bone in HO. A matched case-control study showed that miR-630 is specifically downregulated during the early stages of HO and can be used to distinguish HO from other processes leading to bone formation. Our findings suggest a potential mechanism of post-traumatic ectopic bone formation and identify miR-630 as a potential early indicator of HO.
异位骨化(HO)是指在骨骼外软组织中异常形成成熟骨,其发生是由创伤性损伤引起的炎症或与基因突变相关。尽管为确定成骨祖细胞的来源进行了广泛研究,但HO的细胞起源仍存在争议,而对于HO早期检测至关重要的潜在机制仍不清楚。在此,我们使用BMP4和TGF-β2诱导的HO的体外和体内模型,来确定创伤性HO中异位骨形成的细胞起源和介导机制。我们的结果提示创伤性HO早期异位骨的内皮起源,并表明通过靶向Slug的miR-630抑制内皮-间充质转化在HO异位骨形成中起作用。一项匹配的病例对照研究表明,miR-630在HO早期阶段特异性下调,可用于将HO与其他导致骨形成的过程区分开来。我们的发现提示创伤后异位骨形成的潜在机制,并确定miR-630为HO的潜在早期指标。